MYCN and neoplasm: To determine the impact of N-Myc overexpression and Rb1 loss on tumor progression in vivo, we introduced Rb1f/f alleles into our previously described Pb-Cre4+/−;Ptenf/f;LSL-MYCN+/+ genetically engineered mouse (GEM) model7.